Sage Therapeutics Inc (SAGE)
13.20
+0.17
(+1.30%)
USD |
NASDAQ |
Apr 19, 13:32
Sage Therapeutics Shares Outstanding: 60.11M for Feb. 7, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
February 07, 2024 | 60.11M |
January 16, 2024 | 60.11M |
December 31, 2023 | 60.04M |
December 15, 2023 | 60.03M |
November 30, 2023 | 60.03M |
October 31, 2023 | 59.97M |
September 30, 2023 | 59.97M |
August 01, 2023 | 59.88M |
June 30, 2023 | 59.80M |
April 25, 2023 | 59.76M |
April 17, 2023 | 59.76M |
March 31, 2023 | 59.76M |
February 08, 2023 | 59.72M |
December 31, 2022 | 59.51M |
November 01, 2022 | 59.49M |
September 30, 2022 | 59.49M |
July 27, 2022 | 59.42M |
June 30, 2022 | 59.39M |
April 26, 2022 | 59.07M |
April 19, 2022 | 59.07M |
March 31, 2022 | 59.07M |
February 16, 2022 | 59.05M |
December 31, 2021 | 58.94M |
October 26, 2021 | 58.91M |
September 30, 2021 | 58.83M |
Date | Value |
---|---|
July 27, 2021 | 58.81M |
June 30, 2021 | 58.77M |
April 27, 2021 | 58.48M |
April 13, 2021 | 58.43M |
March 31, 2021 | 58.41M |
February 17, 2021 | 58.38M |
December 31, 2020 | 58.31M |
October 29, 2020 | 52.04M |
September 30, 2020 | 52.02M |
August 04, 2020 | 51.97M |
June 30, 2020 | 51.94M |
April 30, 2020 | 51.92M |
April 13, 2020 | 51.92M |
March 31, 2020 | 51.92M |
February 20, 2020 | 51.91M |
December 31, 2019 | 51.88M |
November 06, 2019 | 51.82M |
September 30, 2019 | 51.82M |
July 31, 2019 | 51.66M |
June 30, 2019 | 51.47M |
April 25, 2019 | 51.15M |
April 08, 2019 | 51.05M |
March 31, 2019 | 51.03M |
February 27, 2019 | 50.93M |
February 12, 2019 | 47.09M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
51.15M
Minimum
Apr 25 2019
60.11M
Maximum
Jan 16 2024
57.05M
Average
58.92M
Median
Shares Outstanding Benchmarks
Biogen Inc | 145.36M |
Gilead Sciences Inc | 1.246B |
Perspective Therapeutics Inc | 586.92M |
QuidelOrtho Corp | 66.85M |
Aethlon Medical Inc | 2.620M |